185 related articles for article (PubMed ID: 35941029)
1. Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment.
Serroukh Y; Hébert J; Busque L; Mercier F; Rudd CE; Assouline S; Lachance S; Delisle JS
Blood Rev; 2023 Jan; 57():100991. PubMed ID: 35941029
[TBL] [Abstract][Full Text] [Related]
2. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
Sauerer T; Velázquez GF; Schmid C
Mol Cancer; 2023 Nov; 22(1):180. PubMed ID: 37951964
[TBL] [Abstract][Full Text] [Related]
3. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
[TBL] [Abstract][Full Text] [Related]
4. Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.
Wang W; Wu X; Zheng J; Yin R; Li Y; Wu X; Xu L; Jin Z
Front Immunol; 2023; 14():1315453. PubMed ID: 38292478
[TBL] [Abstract][Full Text] [Related]
5. Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions.
Guarnera L; Santinelli E; Galossi E; Cristiano A; Fabiani E; Falconi G; Voso MT
Exp Hematol; 2024 Jan; 129():104118. PubMed ID: 37741607
[TBL] [Abstract][Full Text] [Related]
6. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
7. The potential role of the thymus in immunotherapies for acute myeloid leukemia.
Hino C; Xu Y; Xiao J; Baylink DJ; Reeves ME; Cao H
Front Immunol; 2023; 14():1102517. PubMed ID: 36814919
[TBL] [Abstract][Full Text] [Related]
8. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.
Ikegawa S; Doki N; Kurosawa S; Yamaguchi T; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Leuk Lymphoma; 2016; 57(1):76-80. PubMed ID: 26084204
[TBL] [Abstract][Full Text] [Related]
10. Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia.
Lee SE; Yoon JH; Shin SH; Yahng SA; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim M; Lim J; Kim Y; Han K; Kim HJ
Int J Hematol; 2013 May; 97(5):640-9. PubMed ID: 23529846
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation.
Bastos-Oreiro M; Perez-Corral A; Martínez-Laperche C; Bento L; Pascual C; Kwon M; Balsalobre P; Muñoz C; Buces E; Serrano D; Gayoso J; Buño I; Anguita J; Diéz-Martín JL
Eur J Haematol; 2014 Sep; 93(3):239-46. PubMed ID: 24702162
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
13. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
14. Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value.
Nomdedéu JF; Esquirol A; Carricondo M; Pratcorona M; Hoyos M; Garrido A; Rubio M; Bussaglia E; García-Cadenas I; Estivill C; Brunet S; Martino R; Sierra J
Biol Blood Marrow Transplant; 2018 Jan; 24(1):55-63. PubMed ID: 28939453
[TBL] [Abstract][Full Text] [Related]
15. CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Cui Q; Qian C; Xu N; Kang L; Dai H; Cui W; Song B; Yin J; Li Z; Zhu X; Qu C; Liu T; Shen W; Zhu M; Yu L; Wu D; Tang X
J Hematol Oncol; 2021 May; 14(1):82. PubMed ID: 34034795
[TBL] [Abstract][Full Text] [Related]
16. The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.
Isidori A; Salvestrini V; Ciciarello M; Loscocco F; Visani G; Parisi S; Lecciso M; Ocadlikova D; Rossi L; Gabucci E; Clissa C; Curti A
Expert Rev Hematol; 2014 Dec; 7(6):807-18. PubMed ID: 25227702
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract][Full Text] [Related]
18. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.
Novitzky-Basso I; Chen C; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law A; Al-Shaibani Z; Gerbitz A; Pasic I; Mattsson J; Michelis FV
Eur J Haematol; 2021 Sep; 107(3):354-363. PubMed ID: 34076909
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Olson AL; Saliba RM; Oran B; Chen J; Alousi A; Ahmed S; Bashir Q; Ciurea SO; Hosing C; Seon Im J; Kebriaei P; Khouri IF; Mehta R; Nieto Y; Parmar S; Rezvani K; Shah N; Shpall E; Srour SA; Qazilbash M; Andersson BS; Champlin R; Popat UR
Acta Haematol; 2021; 144(1):74-81. PubMed ID: 32604096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
